The 20 Best Bladder Cancer Doctors Near Me

Find Doctors who have experience with Hexaminolevulinate

Last Updated: 11/08/2026

Save doctors for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Already have a doctor?
Find A Second Opinion

MediFind found 96 doctor with experience in Bladder Cancer.

Location
LocationClose
96 providers found
    Elite in Bladder Cancer
    Elite in Bladder Cancer
    Referral may be required

    Einstein Urology At Moss

    1200 West Tabor Road, 3rd Floor Sley, 
    Philadelphia, PA 
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    Edouard Trabulsi is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Trabulsi is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Prostatectomy, and Nephrectomy. Dr. Trabulsi is board certified in Urology. Dr. Trabulsi is currently accepting new patients.

    Elite in Bladder Cancer
    Elite in Bladder Cancer
    Referral may be required

    Prostate Cancer Center

    1825 Fourth St., Sixth Floor, 
    San Francisco, CA 
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    Dr. Sima Porten is a specialist in cancers of the genital and urinary organs. She is a member of the urologic oncology team at the UCSF Helen Diller Family Comprehensive Cancer Center. Her clinical interests include the diagnosis and treatment of genitourinary cancer, particularly bladder cancer, upper tract urothelial cancer, kidney cancer and high-risk prostate cancer. Porten's research focuses mainly on the diagnosis and management of urothelial carcinoma, a cancer involving parts of the kidney, bladder and ureter (the tube connecting each kidney to the bladder). In studying the biologic or genetic basis of urothelial carcinoma, she hopes to develop new tests and treatments to bring personalized medicine to patients with bladder cancer. Porten received her undergraduate, medical and master of public health degrees from Northwestern University. During medical school, she was inducted into the Alpha Omega Alpha Honor Medical Society and also completed a fellowship through the Howard Hughes Medical Institute–National Institutes of Health Research Scholars Program. She then completed her urology residency training at UCSF, where she received the Julius R. Krevans Award for Clinical Excellence. During her training in urologic oncology at the University of Texas MD Anderson Cancer Center, she was awarded a John Quale Travel Fellowship for her research in bladder cancer. Porten is an active member of the American Urological Association, American Society of Clinical Oncology, Society of Women in Urology and Society of Urologic Oncology. Dr. Porten is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Non-Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Porten is board certified in American Board Of Urology, Urology. Dr. Porten is currently accepting new patients.

    Elite in Bladder Cancer
    Elite in Bladder Cancer
    Referral may be required

    UT MD Anderson Cancer Center

    210 Ashville Ave # 408, 
    Cary, NC 
    Languages Spoken:
    English

    Ashish Kamat is a Urologist practicing medicine in Cary, North Carolina. Dr. Kamat is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Cystectomy, and Lymphadenectomy.

    Are you looking for a specific type of Bladder Cancer?

    Common conditions include: Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer

    Learn about our expert tiers
    Elite in Bladder Cancer
    Elite in Bladder Cancer
    Referral may be required

    NYU Langone Internal Medicine Associates

    222 E 41st St, 
    New York, NY 
    Languages Spoken:
    English
    Offers Telehealth

    William Huang is a Urologist practicing medicine in New York, New York. Dr. Huang is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Bladder Cancer, Prostate Cancer, Nephrectomy, and Cystectomy.

    Elite in Bladder Cancer
    Elite in Bladder Cancer
    Referral may be required
    800 N.E. 10th St., Suite 4300, 
    Oklahoma City, OK 
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    Michael Cookson is a Urologist practicing medicine in Oklahoma City, Oklahoma. Dr. Cookson is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, Cystectomy, and Nephrectomy. Dr. Cookson is board certified in American Board Of Urology , Oklahoma State Board Of Medical Licensure & Supervision, Drug Enforcement Administration , and Oklahoma Bureau Of Narcotics And Dangerous Drugs . Dr. Cookson is currently accepting new patients.

    Elite in Bladder Cancer
    Elite in Bladder Cancer
    Referral may be required

    University Of Chicago Medical Center

    5841 S Maryland Ave, 
    Chicago, IL 
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    Gary Steinberg is a Urologist practicing medicine in Chicago, Illinois. Dr. Steinberg is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Cystectomy, and Ureteral Reconstruction. Dr. Steinberg is currently accepting new patients.

    Elite in Bladder Cancer
    Oncology | Surgical Oncology | Urology
    Elite in Bladder Cancer
    Oncology | Surgical Oncology | Urology
    Referral may be required

    Baylor Medicine At McNair - Urology

    7200 Cambridge St., 10th Floor, Suite 10 B, 
    Houston, TX 
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    Seth P. Lerner, MD, is Professor of Urology and holds the Beth and Dave Swalm Chair in Urologic Oncology, in the Scott Department of Urology, Baylor College of Medicine. He is Director of Urologic Oncology and the Multidisciplinary Bladder Cancer Program and Faculty Group Practice Medical Director for the Urology Clinic. He earned his medical degree from Baylor College of Medicine, completed a surgical internship at Virginia Mason Hospital in Seattle, and returned to Baylor for his residency training. He completed a two-year fellowship at the University of Southern California in urologic oncology and reconstructive surgery under Peter Jones and Don Skinner before returning to join the full-time Baylor faculty in 1992. His clinical practice, education, and research activities are devoted to urologic oncology and particularly lower and upper tract urothelial cancer. Dr. Lerner is author of more than 160 peer-reviewed articles, and co-editor of a comprehensive Textbook of Bladder Cancer. Dr. Lerner is an active member of the prestigious American Association of Genitourinary surgeons and is listed routinely among America's Top Doctors and Best Doctors in America. He established and directs the multi-disciplinary Bladder Cancer Research Program at Baylor, and his research interests include use of selective estrogen receptor modulators for treatment of bladder cancer, gene therapy, targeted molecular therapeutics, and outcomes of radical cystectomy and pelvic lymphadenectomy. He has 22 years of experience as a clinical investigator for both NCI and industry funded clinical trials. He is the PI of the ongoing SWOG NCI Phase III trial comparing extended vs. standard pelvic lymphadenectomy at time of radical cystectomy for muscle invasive bladder cancer. He is active in the leadership of several national bladder cancer research enterprises including chair of the Local Bladder Cancer committee of SWOG, co-chair of the NCI's Bladder Cancer Task Force and the Analysis Working Group of The Cancer Genome Atlas Project for muscle invasive bladder cancer. He is very active in the Bladder Cancer Advocacy Network (BCAN) as a member of the Board of Directors, past chair of the Bladder Cancer Think Tank and co-chair of the management committee of the Bladder Cancer Research Network. Dr. Lerner is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Lymphadenectomy. Dr. Lerner is currently accepting new patients.

    Elite in Bladder Cancer
    Oncology | Urology
    Elite in Bladder Cancer
    Oncology | Urology
    Referral may be required

    Johns Hopkins Outpatient Center

    601 North Caroline Street, Floor 4, Floor 4, 
    Baltimore, MD 
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    Dr. Max Kates is the R. Christian B. Evensen Professor and an associate professor of urology and oncology at the Brady Urological Institute at Johns Hopkins. He also directs the Division of Urologic Oncology for the Brady Urological Institute. Dr. Kates completed his undergraduate degree at Wesleyan University in Connecticut before pursuing his medical degree at Mount Sinai School of Medicine in New York. He then went on to train at Johns Hopkins for his urologic residency and Society of Urologic Oncology (SUO) fellowship. Dr. Kates has expertise in all areas of urologic oncology, with a particular emphasis on bladder and prostate cancer. With training in open, endoscopic, and robotic surgical approaches, Dr. Kates’ surgical philosophy is to assess the unique needs of each patient, and develop the right treatment plan for their malignancy. He is very hands on in his approach in the clinic and the operating room, and believes open communication with the patient, the patient’s family, and referring providers is key to ensuring a speedy recovery. As the clinical director of the bladder cancer multidisciplinary clinic, Dr. Kates works with the team at the Johns Hopkins Greenberg Bladder Cancer Institute to deliver a personalized approach to bladder cancer utilizing cutting edge precision medicine approaches. Dr. Kates’ research interests involve novel treatments for cancers of the urinary tract. Dr. Kates has authored more than 135 journal articles in the fields of bladder, prostate, and kidney cancer. He currently has a provisional patent for a novel intravesical chemotherapy developed with nano-engineer collaborators. Additionally, Dr. Kates has made important discoveries into the mechanism of action of intravesical BCG, the most common treatment for bladder cancer. He is the principal investigator on multiple trials, and is currently leading EA8212 BRIDGE, which is a randomized trial open in over 150 centers in the United States comparing BCG to GemDoce chemotherapy for early stage bladder cancer. To inquire about an appointment or make a referral, Dr. Kates can be contacted by phone (410) 614-0009. Dr. Kates is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Kates is board certified in American Board Of Urology. Dr. Kates is currently accepting new patients.

    Distinguished in Bladder Cancer
    Oncology | General Surgery
    Distinguished in Bladder Cancer
    Oncology | General Surgery
    Referral may be required

    Jefferson Urology – Honickman Center

    1101 Chestnut Street, Floor 11, 
    Philadelphia, PA 
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    Leonard Gomella is an Oncologist and a General Surgeon practicing medicine in Philadelphia, Pennsylvania. Dr. Gomella is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Bladder Cancer, Familial Prostate Cancer, Prostatectomy, and Cystectomy. Dr. Gomella is board certified in Urology. Dr. Gomella is currently accepting new patients.

    Elite in Bladder Cancer
    Elite in Bladder Cancer
    Referral may be required

    UT Southwestern - Urology

    5323 Harry Hines Blvd, 
    Dallas, TX 
    Languages Spoken:
    English, Russian, Spanish
    Accepting New Patients
    Offers Telehealth

    Vitaly Margulis is a Urologist practicing medicine in Dallas, Texas. Dr. Margulis is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Upper Tract Urothelial Carcinoma (UTUC), Urothelial Cancer, Renal Cell Carcinoma (RCC), Nephrectomy, and Orchiectomy. Dr. Margulis is currently accepting new patients.

    Elite in Bladder Cancer
    Elite in Bladder Cancer
    Referral may be required

    Southern Sierra Medical Clinic

    105 E Sydnor Ave, Ste 100, 
    Ridgecrest, CA 
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    Anne Schuckman is a Urologist practicing medicine in Ridgecrest, California. Dr. Schuckman is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Bladder Reconstruction. Dr. Schuckman is currently accepting new patients.

    Elite in Bladder Cancer
    Urology | Oncology
    Elite in Bladder Cancer
    Urology | Oncology
    Referral may be required

    CUIMC/Herbert Irving Pavilion

    161 Fort Washington Avenue, 
    New York, NY 
    Languages Spoken:
    English, Spanish
    Accepting New Patients
    Offers Telehealth

    James McKiernan, MD, is the John K. Lattimer Professor of Urology and CEO of ColumbiaDoctors. He is also Senior Vice Dean for Clinical Affairs for Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues.For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer. Dr. Mckiernan is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy. Dr. Mckiernan is board certified in Urology. Dr. Mckiernan is currently accepting new patients.

    Elite in Bladder Cancer
    Elite in Bladder Cancer
    Referral may be required
    Hoppe Seyler Str. 3, 
    Tuebingen, BW, DE 

    Arnulf Stenzl practices practicing medicine in Tuebingen, Germany. Mr. Stenzl is rated as an Elite expert by MediFind in the treatment of Bladder Cancer. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Prostate Cancer, Renal Cell Carcinoma (RCC), Cystectomy, and Lymphadenectomy.

    Elite in Bladder Cancer
    Elite in Bladder Cancer
    Referral may be required

    Medical Pavilion

    2000 Olathe Boulevard, 
    Kansas City, KS 
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    Jeffrey Holzbeierlein is an Oncologist practicing medicine in Kansas City, Kansas. Dr. Holzbeierlein is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Holzbeierlein is board certified in American Board Of Urology, Urology - 2004. Dr. Holzbeierlein is currently accepting new patients.

    Elite in Bladder Cancer
    Elite in Bladder Cancer
    Referral may be required

    Cedars-Sinai Urology-Los Angeles

    8635 W 3rd St Ste 1070W Ofc West, 
    Los Angeles, CA 
    Languages Spoken:
    English
    Offers Telehealth

    Stephen Freedland is a Urologist practicing medicine in Los Angeles, California. Dr. Freedland is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Enlarged Prostate (BPH), Prostatectomy, and Cystectomy.

    Elite in Bladder Cancer
    Elite in Bladder Cancer
    Referral may be required

    Prostate Cancer Center

    1825 Fourth St., Sixth Floor, 
    San Francisco, CA 
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    Dr. Maxwell Meng is a surgeon specializing in urologic cancers and laparoscopy. His interests in patient care include diagnosing and managing cancers of the genital and urinary organs, as well as minimally invasive treatments of both benign and malignant diseases. He is experienced in robotic surgery. Meng is active in research to develop new treatment technologies. Meng earned his medical degree at Johns Hopkins School of Medicine. He completed general surgery and urology training at UCSF, where he also completed fellowships in urologic oncology and minimally invasive surgery. Dr. Meng is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Meng is board certified in American Board Of Urology, Urology. Dr. Meng is currently accepting new patients.

    Elite in Bladder Cancer
    Surgical Oncology | Oncology
    Elite in Bladder Cancer
    Surgical Oncology | Oncology
    Referral may be required

    Allina Health Cancer Institute - Minneapolis

    913 East 26th Street, 
    Minneapolis, MN 
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    What is your practice philosophy?Patient focused, evidenced based care tailored to the patient and family values and needs. Dr. Konety is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, Lymphadenectomy, and Endoscopy. Dr. Konety is board certified in American Board Of Urology,2003 and Urology. Dr. Konety is currently accepting new patients.

    Elite in Bladder Cancer
    Elite in Bladder Cancer
    Referral may be required

    Office

    1516 San Pablo St Ste 3500, 
    Los Angeles, CA 
    Languages Spoken:
    English
    Offers Telehealth

    Siamak Daneshmand is a Urologist practicing medicine in Los Angeles, California. Dr. Daneshmand is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Testicular Cancer, Cystectomy, and Bladder Reconstruction.

    Elite in Bladder Cancer
    Elite in Bladder Cancer
    Referral may be required

    JPS Health Network

    1500 S Main St, 
    Fort Worth, TX 
    Languages Spoken:
    English
    Offers Telehealth

    Yair Lotan is a Urologist practicing medicine in Fort Worth, Texas. Dr. Lotan is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 44 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Upper Tract Urothelial Carcinoma (UTUC), Cystectomy, and Nephrectomy.

    Elite in Bladder Cancer
    Elite in Bladder Cancer
    Referral may be required

    Penn Urology Perelman

    3400 Civic Center Boulevard, West Pavilion, 3rd Floor, 
    Philadelphia, PA 
    Languages Spoken:
    English

    Trinity Bivalacqua is a Urologist practicing medicine in Philadelphia, Pennsylvania. Dr. Bivalacqua is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Prostatectomy.

    Showing 1-20 of 96

    Last Updated: 11/08/2026

    What is the definition of Bladder Cancer?

    Bladder cancer is a malignancy of the organ in the lower abdomen that stores urine and is the sixth most common cancer in the U.S. Bladder cancer frequently starts in the cells lining the bladder (urothelial cells); however, it can also occur in other types of bladder cells as well as include more than one type of cell. Three types of bladder cancer that begin in the cells lining the bladder (urothelial cells) are 1) urothelial carcinoma, which is also called transitional cell carcinoma; 2) squamous cell carcinoma; and 3) adenocarcinoma. Urothelial carcinoma (Transitional cell carcinoma) – Urothelial carcinoma, which is the most common type of bladder cancer in the U.S., is found in the cells lining the inside of the bladder (urothelial), which expand when the bladder is full and contract when it is empty. Squamous cell carcinoma – Squamous cell carcinoma can occur from chronic bladder irritation, such as frequent bladder infections or long-term catheterization. While rare in the U.S., this cancer is common in other countries where parasite infections called schistosomiasis cause frequent bladder infections. Adenocarcinoma – Adenocarcinoma occurs in the glands of the bladder that secrete mucus and is rare in the U.S. Bladder cancer is further classified as either non-muscle invasive bladder cancer (NMIBC) or muscle-invasive bladder cancer (MIBC). Non-muscle invasive bladder cancer (NMIBC) – Non-muscle invasive bladder cancer is the most common type of bladder cancer, and usually does not spread (metastasize); however, it frequently recurs after treatment. Muscle-invasive bladder cancer (MIBC) – Muscle-invasive bladder cancer spreads to the muscle wall of the bladder and can be life-threatening. Bladder cancer is also categorized by the following stages: Stage 0 (0a and Ois) – Non-invasive papillary carcinoma or carcinoma in situ, with abnormal cells that may become cancerous and spread (metastasize). Stage I – Cancer has spread to the connective beyond the inner lining of the bladder (urothelial cells). Stage II – Cancer has spread to the muscle layers of the bladder. Stage III (IIIA and IIIB) – Cancer has spread to the fat outside the bladder, and possibly the reproductive organs, such as uterus, vagina, prostate, or seminal vesicles; or cancer has spread to one pelvic lymph node. Stage IV (IVA an IVB) – Cancer has spread from bladder to the lining of the abdomen (peritoneum) or pelvis; or cancer has spread to lymph nodes above common iliac arteries. Cancer has spread (metastasized) to other parts of the body, such as liver, lung, and bone. Bladder cancers are further categorized based on the appearance of cells, as either a low-grade bladder tumor or high-grade bladder tumor. Low-grade bladder tumor – Low-grade bladder tumor has cells that look more like normal cells, grows slowly, and is usually non-invasive (does not spread). High-grade bladder tumor – High-grade bladder tumor has cells that look abnormal, is more aggressive, and is usually invasive (spreads). The stage and grade of bladder cancer determines its treatment and outcome (prognosis).

    When should I see a Bladder Cancer doctor near me?

    There are various reasons why you may want to see a specialist, such as: 

    • Your primary care provider recommends it. 
    • Your condition requires expert knowledge and specialized care. 
    • Your symptoms persist or worsen despite treatment. 
    • You need specialized testing or procedures. 
    • You want a second opinion.  

    What should I consider when choosing a Bladder Cancer doctor near me?

    It’s important to see a provider with expertise in your specific condition. Each provider profile in MediFind’s doctor database includes information on which conditions they treat, years of experience, research contributions, languages spoken, insurance plans accepted, and more.  

    How does MediFind rank Bladder Cancer doctors near me?

    MediFind’s rankings are based on a variety of data sources, such as the number of articles a doctor has published in medical journals, participation in clinical trials and industry conferences, as well as the number of patients that provider sees for a given condition. Note that MediFind’s provider database is not based on user reviews, and providers do not pay to be included in the database. 

    What types of insurance are accepted by Bladder Cancer doctors near me?

    Most profiles in MediFind’s doctor database include a list of insurance plans accepted by that provider. However, it’s a good idea to contact the provider’s office to make sure they still accept your insurance, then doublecheck by contacting your insurance plan to confirm they’re in network. 

    How can I book an appointment online with a Bladder Cancer doctor near me?

    MediFind offers direct scheduling for certain providers using the “Request Appointment” button on that provider’s profile. If the schedule option is not available for a provider, tap the red “Show Phone Number” button on their profile to get their contact information. If you prefer to find providers who offer online scheduling, select “Schedules online” under the “Availability” category of the filter feature on the left side of the Bladder Cancer doctor search results page. 

    Why is it important to get a second opinion from a different Bladder Cancer doctor?

    Second opinions are an opportunity to confirm a diagnosis and its root cause, learn about alternative treatment options, or simply gain peace of mind. Many people, especially those with serious diagnoses, get second opinions so they can understand all their options and make informed decisions, so don’t hesitate to get one if you have any doubts or need more information or clarification regarding your care. Note that some insurance plans require second opinions, while others don’t cover second opinions, so be sure to confirm with your insurance provider first.   

    How can I prepare for my appointment with a Bladder Cancer doctor near me?

    Prepare for your appointment by gathering the following items: 

    • Copies of medical records (dating back at least one year) 
    • Your medical history, including illnesses, medical conditions, surgeries, and other doctors you see 
    • Family history of disease 
    • List of current prescription drugs, over-the-counter medicines, vitamins, and herbal remedies or supplements including names and doses 
    • Allergies to medications, food, latex, insects, etc.  
    • List of questions and concerns 
    • Your insurance card 

    You might also contact the provider’s office to see if they offer transportation or childcare services or if you’re allowed to bring a loved one for support or to take notes during your visit. 

    What questions should I ask my Bladder Cancer doctor?

    Here are some sample questions: 

    • Can you explain in simple terms what this condition is and how it’s treated? 
    • What symptoms or side effects should I watch for? 
    • What tests will be involved, and when can I expect results? 
    • Are there other specialists I need to see? 
    • What’s the best way to reach you if I have follow-up questions? 

    How can I learn about the latest clinical trials and research advances my Bladder Cancer doctor may know about?

    MediFind’s Clinical Trials tool asks you a series of questions to help you narrow down your search by health condition, age, gender, location, how far you’re willing to travel, and more. Each question you answer filters down the number of trials until you find the ones that are most relevant to you. 

    MediFind’s Latest Advances tool features summaries of recent articles published in medical journals. We use cutting-edge technology to scour medical publication databases for the latest research advancements on any given condition, then we simplify this information in a way that’s useful and easy to understand. 

    Can I filter my search to show male or female Bladder Cancer doctors near me?

    Look for the filter feature on the left side of the Bladder Cancer doctor search results page. Select “Female” or “Male” under the “Gender” category to search for female or male providers exclusively. If the “Any” option is selected, it will pull results for both male and female providers. 

    Can I filter my search to find a Bladder Cancer doctor that offers video calls?

    Look for the filter feature on the left-side of the Bladder Cancer doctor search results page. Select “Offers telehealth visits” under the Availability category to search for providers who offer virtual appointments (video calls). 

    Reviewed on: 11/11/24  

    By: MediFind Medical Staff 

    Read more about our Content Policy.